Topic 1

What general frameworks are used to assess risk/benefit in non-pharmaceutical industries or organizations?

(20 minute presentations)

8:45 am

Understanding the psychology of risk/benefit assessment


Discussion Leader: Jeffrey Leiden, M.D., Ph.D.


Paul Slovic, Ph.D.

President, Decision Research


Peter Ubel, M.D.

Director, Center for Behavioral and Decision Sciences in Medicine, University of Michigan


Sheila Jasanoff, J.D., Ph.D.

Professor, John F. Kennedy School of Government, Harvard University

9:45 am


10:05 am


10:20 am

Assessing the effectiveness of risk/benefit algorithms from other industries


Discussion Leader: Steven Galson, M.D., M.P.H.


Dennis Paustenbach, Ph.D.

President, ChemRisk


Jonathan M. Samet, M.D., M.S.

Professor and Chair, Department of Epidemiology, Johns Hopkins University


Joshua T. Cohen, Ph.D.

Lecturer, Tufts New England Medical Center


Richard Hall, Ph.D.

Vice President, Science and Technology (retired), McCormick & Company, Inc.

11:40 am


12:00 pm


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement